BSEAGM/EGM29 Sept 2026 · 29 Sept 2026, 02:38 pm
Outcome and Proceedings of 32nd AGM of the Company held on 29th September, 2026
Advik Laboratories Ltd · 531686
✦ AI SummaryResults
The 32nd Annual General Meeting (AGM) of Advik Laboratories Ltd was held on September 29, 2026, where the company's audited financial statements for the year ended March 31, 2026, were adopted, and various resolutions were passed, including the re-appointment of the statutory auditors and the appointment of an independent director.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Advik Laboratories Ltd - 531686 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Attachments (1)
📄pdf
Download →
ae74f6ac-ed5a-4b86-b850-d6dac8592648.pdf
View document text
MPS PHARMAA LIMITED
(Formerly Advik Laboratories Limited)
Dated: 29th September, 2026
The Manager (Listing),
Bombay Stock Exchange Limited,
01st Floor, P. J. Towers,
Dalal Street, Mumbai - 400001
Sub: Outcome and Proceedings of 32nd Annual General Meeting of the Company held on 29th September, 2026
Ref: BSE Scrip Code 531686; ASE Scrip Code- 01636 (ADVIK LABO); ISIN No: INE537C01019
Dear Sir,
We wish to inform you that the 32nd Annual General Meeting of the Company was duly held on Tuesday, 29th
September, 2026 and the business mentioned in the notice was duly transacted.
In this regard, please find mentioned hereinbelow the proceedings of the 32nd Annual General Meeting of the
Company held on 29th September, 2026 at 9:30 A.M for your kind reference and records:
Mr. Peeyush Kumar Aggarwal was elected as the Chairman of the meeting by show of hands. The Chairman
welcomed the Members of the Company and commenced the proceedings.
The requisite quorum was present and the Meeting was called to order.
The Chairman introduced the Directors, Management Committee Members and the Invitees present at the
meeting.
The Chairman then informed that the Notice of the AGM along with the Audited Standalone Financial
Statements of the Company for the Financial Year ended March 31, 2026, and the report of Board of Directors
thereon, were already circulated electronically within the required timeframe to those shareholders whose
email ids are registered with the Registrar and Share Transfer Agent (RTA) or Depository Participant.
Furthermore, it was also informed that the Company had dispatched a letter to shareholders whose email
addresses were not registered with the Registrar and Transfer Agent or Depository Participant, which
included a web link to access the Annual Report on the Company's website.
The Chairman delivered his speech and the Notice convening the meeting was taken as read with the
permission of the members present. Thereafter, the Chairman read the Auditors’ Report and requested the
members to raise their queries. He clarified the queries raised by the shareholders to their satisfaction.
The Chairman informed the members present that statutory books were kept open for inspection and the
members desiring of inspecting the statutory books may inspect the same.
The Chairman further informed the Members present at the meeting that the remote e-Voting has been closed
on 28th September, 2026 at 05.00 P.M. and requested the members who have not exercised their vote through
e-Voting to cast their votes by ballot on the following items of business included in the Notice of 32nd Annual
General Meeting and the members were further informed by the Chairman that Mr. Kundan Agarwal (FCS:
CIN No. : L74899HR1994PLC038300
Corporate Office : 703, Arunachal building 19, Barakhamba Road, Connaught Place, New Delhi 110001
Phones: 011-42424884, 43571040-45, Fax: 011-43571047
Regd. Office & Factory: 138. Roz-Ka-Meo Industrial Area, Sohna - 122103 (Distt.Mewat), Haryana
Phones: 0124-2362471 Email: info@mpspharmaa.com Website: www.mpspharmaa.com
MPS PHARMAA LIMITED
(Formerly Advik Laboratories Limited)
8325) from Kundan Agrawal & Associates, Practicing Company Secretaries, is appointed as a Scrutinizer for
remote e-voting & polling process.
The Chairman further informed that the Company had taken all requisite steps to enable members to
participate and vote on the items of the businesses considered at the meeting.
Thereafter, the following resolutions set out in the Notice convening the AGM were read by the Chairman of
the meeting:
S. NO. PARTICULARS OF BUSINESS NATURE OF RESOLUTION
Ordinary Business:
1. Adoption of Audited Financial Statements of the Ordinary
company including the Balance Sheet of the Company
as at 31st March, 2026 and the Statement of Profit and
Loss of the Company for the financial year ended 31st
March, 2026 together with the Cash Flow Statement &
other Annexures thereof and the Report of the Board
of Directors and Auditors thereon.
2. To appoint a Director in place of Mr. Ram Niwas Ordinary
Sharma (DIN:08427985), who is liable to retire by
rotation and being eligible, offers himself for re-
appointment pursuant to the provisions of Section 152
of the Companies Act, 2013.
3. Re-appointment of M/s Nemani Garg Agarwal & Co., Ordinary
Chartered Accountants as the Statutory Auditors of the
Company.
Special Business:
4. Approval for Related Party Transactions under Section Ordinary
188 of the Companies Act, 2013 and Regulation 23 Of
SEBI (LODR) Regulations, 2015.
5. Appointment of Ms. Anchal Goyal (DIN 10751205) as Special
an Independent Director of the Company.
6. Approval Of Transactions Under Section 185 Of The Special
Companies Act, 2013
The shareholders present, who have not casted their vote through remote e-voting, casted their vote in Ballot
Form provided to them at the beginning of the Annual General Meeting and put their ballot forms in the Ballot
Box duly locked and sealed by the Scrutinizer, in the presence of the Scrutinizer and Chairman and other
persons.
The Chairman then informed the members that the combined results of the voting on the resolutions, along
with the Scrutinizer’s Report, would be intimated to the BSE Limited and ASE Limited & to the Registrar of
Companies, NCT of Delhi & Haryana and that they would also be placed on the Company’s website and on the
website of National Securities Depository Limited within 02 working days of the AGM.
CIN No. : L74899HR1994PLC038300
Corporate Office : 703, Arunachal building 19, Barakhamba Road, Connaught Place, New Delhi 110001
Phones: 011-42424884, 43571040-45, Fax: 011-43571047
Regd. Office & Factory: 138. Roz-Ka-Meo Industrial Area, Sohna - 122103 (Distt.Mewat), Haryana
Phones: 0124-2362471 Email: info@mpspharmaa.com Website: www.mpspharmaa.com
MPS PHARMAA LIMITED
(Formerly Advik Laboratories Limited)
Before concluding, the Chairman thanked all the shareholders for attending this meeting and extending their
co- operation. Further, he also thanked all the employees for their trust and generous support and declared
the meeting closed at 10:15 A.M.
This intimation is given pursuant to Regulation 30, Part A of Schedule III of the SEBI (Listing Obligation and Disclosure
Requirements) Regulation, 2015.
You are hereby requested to take the aforesaid proceedings of the 32nd Annual General Meeting of the Company in your
records.
Thanking You.
Yours Truly,
For MPS Pharmaa Limited
(Formerly known as Advik Laboratories Limited )
Pooja Chuni
Company Secretary
The Manager (Listing)
Ahmedabad Stock Exchange Limited
01st Floor, Kamdhenu Complex, Opp. Sahajanand College,
Panjara Pole, Ambawadi, Ahmedabad – 380015
CIN No. : L74899HR1994PLC038300
Corporate Office : 703, Arunachal building 19, Barakhamba Road, Connaught Place, New Delhi 110001
Phones: 011-42424884, 43571040-45, Fax: 011-43571047
Regd. Office & Factory: 138. Roz-Ka-Meo Industrial Area, Sohna - 122103 (Distt.Mewat), Haryana
Phones: 0124-2362471 Email: info@mpspharmaa.com Website: www.mpspharmaa.com